C-reactive protein, immunothrombosis and venous thromboembolism
Article
[키워드] activating
amplifying
appear
binding
Biomarker
C-reactive protein
classical
Clinical data
Clinical practice
clinical utility
Complement pathway
condition
conserved
COVID-19
CRP
destabilized
dissociate
Effect
elevated
Elevation
Evidence
Features
immunothrombosis
Infection
Inflammation
Inflammatory bowel disease
Inflammatory response
isoform
marker
membrane
monomeric
Pathogenesis
Platelet
pro-inflammatory
pro-thrombotic
Prophylactic
Protein
raise
required
Sepsis
subset
therapeutic strategy
Thromboinflammation
thrombosis
tissue damage
triggering
utility
Venous Thromboembolism
VTE
VTE risk
with COVID-19
[DOI] 10.3389/fimmu.2022.1002652 PMC 바로가기
[DOI] 10.3389/fimmu.2022.1002652 PMC 바로가기